Corbus Pharmaceuticals Announces Issuance of Composition of Matter Patent Related to Lenabasum
Company’s vision is to become the leader in the treatment of inflammatory and fibrotic diseases by targeting the endocannabinoid system […]
Diana Shipping Inc. Announces Date for Its 2019 Annual Meeting of Shareholders
ATHENS, Greece, Dec. 18, 2018 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing […]
Gulfport Energy Corporation Appoints David M. Wood President, Chief Executive Officer and Member of the Board of Directors
Brings Four Decades of Oil and Gas Industry Expertise to Gulfport OKLAHOMA CITY, Dec. 18, 2018 (GLOBE NEWSWIRE) — Gulfport […]
Nemaura Medical Announces Pricing of Up to $2.5 Million Public Offering
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous […]
FTE Networks Executes Term Sheet to Amend Existing Senior Credit Facility
Extends maturity of credit facility to March 30, 2021 NAPLES, Fla., Dec. 18, 2018 (GLOBE NEWSWIRE) — FTE Networks, Inc. […]
First Solar Series 6 Completes CSA C450 Test Protocol at CSA Group’s PV Test Lab CFV Solar
Test validates performance in extreme, harsh conditions Thresher and Long Term Sequential certifications also achieved TEMPE, Ariz., Dec. 18, 2018 […]
Matthew Costello Joins Cowen’s Capital Introduction Team
NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) today announced that Matthew Costello […]
IEEE Recognizes Contributions of Two InterDigital Engineers With Board Seat, Best Paper Award
WILMINGTON, Del., Dec. 18, 2018 (GLOBE NEWSWIRE) — The contributions of two engineers from InterDigital, Inc. (NASDAQ: IDCC), a mobile […]
Portola Pharmaceuticals to Webcast Corporate Update on January 8, 2019
SOUTH SAN FRANCISCO, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) — Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that Scott Garland, […]
Intra-Cellular Therapies Announces Update on ITI-007-201 Clinical Trial for Treatment of Agitation in Patients with Probable Alzheimer's Disease
NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of […]
